Concepedia

New Zealand Epidemic Strain Meningococcal B Outer Membrane Vesicle Vaccine in Children Aged 16–24 Months

Sharon Wong, Diana Lennon, Catherine Jackson, Joanna Stewart, Stewart Reid, Sue Crengle, Sandrine Tilman, Ingeborg S. Aaberge, Jane O’Hallahan, Philipp Oster,

The Pediatric Infectious Disease Journal · 2007 · 50 citations · 20 references

DOI

Abstract

The New Zealand candidate vaccine administered to these 16-24-month-old children in 3 doses was safe and elicited a promising immune response against the candidate vaccine strain NZ98/254 (N. meningitidis B:4:P1.7b,4) contributing to vaccine licensure for this age group.

References

20

Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway

G Bjune, E. Arne Høiby, Jon Ketil Grønnesby et al. · The Lancet · 1991 · 693 citations

, , +8

Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba.

G V Sierra, H C Campa, N M Varcacel et al. · PubMed · 1991 · 514 citations

, , +15

Immunogenicity of 2 Serogroup B Outer-Membrane Protein Meningococcal Vaccines

Jordan W. Tappero, A. Maldonado Ballesteros, D Williams et al. · JAMA · 1999 · 371 citations

Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil

José Cássio de Moraes, Maria Cláudia Corrêa Camargo, Neuma T. Hidalgo et al. · The Lancet · 1992 · 367 citations

, , +10

Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile

J. Boslego · Vaccine · 1995 · 266 citations

, , +8